The ability of antibodies against the full length PfRh5 (RH5FL) protein to inhibit the growth of all strains of parasites in vitro more effectively than antibodies induced by other vaccine candidates, such as AMA-1 and MSP-1, increased the appeal of using PfRh5 as an anti-blood-stage malaria vaccine [27]. This evidence concerns the gene ATAD1 and malaria.